☆ 4.8 Article

Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: It is mostly ineffective, is expensive, and may rarely cause serious adverse events

HEPATOLOGY (2014)

Get Full Text
Add to Collection

Journal

HEPATOLOGY
Volume 60, Issue 5, Pages 1786-1788

Publisher

Wiley
DOI: 10.1002/hep.27363

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.